Starpharmaの収入
Starpharmaの収入 は何ですか。
Starpharma Holdings Limitedの収入 は-8.17AUD$です。
収入 の定義は何ですか。
普通株主に帰属する当期純利益は、純利益から優先配当金を差し引いた金額です。優先配当
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
ASXのセクタHealth Careにおける収入 の企業と比べるStarpharma
Starpharmaは何をしますか。
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Starpharmaと類似の収入
- FireAngel Safety Technology plcの収入 は-8.20£です。
- HPQ-Silicon Resourcesの収入 は-8.20CAD$です。
- Scotgold Resourcesの収入 は-8.20AUD$です。
- Salter Bros Emerging Co Ltdの収入 は-8.19AUD$です。
- Wisrの収入 は-8.19AUD$です。
- Hudson Capitalの収入 は-8.18$です。
- Starpharmaの収入 は-8.17AUD$です。
- The Westaimの収入 は-8.17$です。
- Exicure Incの収入 は-8.17$です。
- Simondsの収入 は-8.17AUD$です。
- CBD Global Sciencesの収入 は-8.17$です。
- YayYoの収入 は-8.17$です。
- Medicinova Incの収入 は-8.17$です。